Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 1
1969 1
1970 2
2002 1
2005 1
2007 4
2008 2
2009 3
2010 4
2011 3
2012 2
2013 7
2014 7
2015 10
2016 10
2017 16
2018 12
2019 22
2020 13
2021 13
2022 19
2023 13
2024 17
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.
Fonseca NM, Maurice-Dror C, Herberts C, Tu W, Fan W, Murtha AJ, Kollmannsberger C, Kwan EM, Parekh K, Schönlau E, Bernales CQ, Donnellan G, Ng SWS, Sumiyoshi T, Vergidis J, Noonan K, Finch DL, Zulfiqar M, Miller S, Parimi S, Lavoie JM, Hardy E, Soleimani M, Nappi L, Eigl BJ, Kollmannsberger C, Taavitsainen S, Nykter M, Tolmeijer SH, Boerrigter E, Mehra N, van Erp NP, De Laere B, Lindberg J, Grönberg H, Khalaf DJ, Annala M, Chi KN, Wyatt AW. Fonseca NM, et al. Among authors: van erp np. Nat Commun. 2024 Feb 28;15(1):1828. doi: 10.1038/s41467-024-45475-w. Nat Commun. 2024. PMID: 38418825 Free PMC article.
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer.
Tolmeijer SH, Boerrigter E, Sumiyoshi T, Kwan EM, Ng SWS, Annala M, Donnellan G, Herberts C, Benoist GE, Hamberg P, Somford DM, van Oort IM, Schalken JA, Mehra N, van Erp NP, Wyatt AW. Tolmeijer SH, et al. Among authors: van erp np. Clin Cancer Res. 2023 Aug 1;29(15):2835-2844. doi: 10.1158/1078-0432.CCR-22-2998. Clin Cancer Res. 2023. PMID: 36996325
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.
Moes DJAR, Hendrikx JJMA, Guchelaar HJ, Mathijssen RHJ, Bakker JL, Dezentjé VO, de Rouw N, van Erp NP, Smit EF, van den Heuvel MM, Munnink THO, van Kats M, Croes S, Kroep JR, Zwaveling J, Ter Heine R. Moes DJAR, et al. Among authors: van erp np. Target Oncol. 2024 Sep;19(5):789-796. doi: 10.1007/s11523-024-01075-8. Epub 2024 Jun 18. Target Oncol. 2024. PMID: 38890221 Free PMC article.
A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups.
Mohmaed Ali MI, Nijstad AL, Boosman RJ, Crombag MBS, Barnett S, Veal GJ, Lalmohamed A, van Erp NP, Steeghs N, Zwaan CM, Beijnen JH, Siebinga H, Huitema ADR. Mohmaed Ali MI, et al. Among authors: van erp np. Clin Pharmacokinet. 2024 Dec;63(12):1711-1722. doi: 10.1007/s40262-024-01445-5. Epub 2024 Nov 16. Clin Pharmacokinet. 2024. PMID: 39549227
Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study.
van der Kleij MBA, Guchelaar NAD, Meertens M, Westerdijk K, Giraud EL, Bleckman RF, Groenland SL, van Eerden RAG, Imholz ALT, Vulink AJE, Otten HM, Fiebrich-Westra HB, Lubberman FJE, Desar IME, Moes DAR, Touw DJ, Koolen SLW, Gelderblom H, Reyners AKL, van Erp NP, Mathijssen RHJ, Huitema ADR; Dutch Pharmacology Oncology Group (DPOG); Steeghs N. van der Kleij MBA, et al. Among authors: van erp np. Br J Cancer. 2024 Sep;131(5):843-851. doi: 10.1038/s41416-024-02789-2. Epub 2024 Jul 6. Br J Cancer. 2024. PMID: 38971952 Free PMC article.
Mammalian target of rapamycin inhibitor-associated stomatitis.
Boers-Doets CB, Raber-Durlacher JE, Treister NS, Epstein JB, Arends AB, Wiersma DR, Lalla RV, Logan RM, van Erp NP, Gelderblom H. Boers-Doets CB, et al. Among authors: van erp np. Future Oncol. 2013 Dec;9(12):1883-92. doi: 10.2217/fon.13.141. Future Oncol. 2013. PMID: 24295418 Review.
167 results